2019
DOI: 10.1016/j.tibtech.2019.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Systems Metabolic Engineering Strategies: Integrating Systems and Synthetic Biology with Metabolic Engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
217
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 399 publications
(238 citation statements)
references
References 194 publications
0
217
0
Order By: Relevance
“…Our analysis predicts regulatory mechanisms that will likely orchestrate flux adjustments based on reaction attributes. This can guide drug discovery and metabolic engineering efforts by identifying regulators that are dominant in different parts of the network [44]. CAROM can be applied to uncover target specificities of other regulators such as non-coding RNAs and PTMs, and help understand the architecture of metabolic regulation in a wide range of organisms.…”
Section: Resultsmentioning
confidence: 99%
“…Our analysis predicts regulatory mechanisms that will likely orchestrate flux adjustments based on reaction attributes. This can guide drug discovery and metabolic engineering efforts by identifying regulators that are dominant in different parts of the network [44]. CAROM can be applied to uncover target specificities of other regulators such as non-coding RNAs and PTMs, and help understand the architecture of metabolic regulation in a wide range of organisms.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, systems metabolic engineering was emphasized as an integral part in the development and optimization of microbial cell factories (Wittmann and Lee, 2012;Maia et al, 2016;Saa et al, 2019;Choi et al, 2019;Sarkar and Maranas, 2019). Thus, we want to put the PAM forth to highlight the advantages of considering the allocation of the total condition-dependent proteome for constraint-based modeling techniques in favor of more accurate mutant strain predictions.…”
Section: Discussionmentioning
confidence: 99%
“…Pharmaceutical companies are already investing substantially in computational approaches to guide drug discovery and cell design. While these important applications are out of the scope of this paper, we refer the interested readers to detailed reviews on the usage of metabolic engineering and synthetic biology in industrial context [5][6][7][8] . However, model-based methods can be used for much more than this.…”
Section: Introductionmentioning
confidence: 99%